Julian GS, Rosim RP, Carneseca EC, Rigolon J, et al. Annualized hospitalization rate with natalizumab vs fingolimod in second-line
treatment for RRMS in the public healthcare system in Brazil: A claim database
approach. PLoS One 2020;15:e0229768.
PMID: 32119696